| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, Purvalanol A, CDK1/Cyclin B Inhibitors;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase (DYRK) Inhibitors;CDK2/Cyclin A Inhibitors;CDK4/Cyclin D1 Inhibitors;CDK2/Cyclin E Inhibitors;CDK5 Inhibitors targeting CHUK, CCNA1, CCNB2, CCNE2, CCNB3 (Novartis, 456214) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/456214 |
| Similar Terms | |
| Downloads & Tools |
1 genes differentially expressed following the AA-49-BD04_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|
| Symbol | Name | Standardized Value |
|---|---|---|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | -0.270718 |